ArticlePlant communications2026
Multi-omics and functional analyses in Aesculus wilsonii elucidate the biosynthetic pathways of moretane- and oleanane-type triterpenoids.
Article in Plant communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Aesculus wilsonii, a medicinal tree widely used in traditional Chinese medicine, is rich in aescin and other structurally diverse triterpenoids; however, the biosynthetic basis underlying this chemical diversity remains poorly understood. In this study, we combined integrated multi-omics analyses with functional characterization to elucidate triterpenoid biosynthesis in A. wilsonii. Metabolomic profiling annotated 135 triterpenoids, which were classified into nine distinct skeleton types, including one previously uncharacterized scaffold. A near telomere-to-telomere genome assembly, together with seven transcriptomes, enabled comprehensive analyses of genome organization and evolution and led to the identification of four triterpenoid biosynthetic gene clusters (TBGC-1 to TBGC-4). Comparative genomics and co-expression analyses uncovered A. wilsonii-specific cytochrome P450 (CYP) genes. Functional characterization of seven CYPs in yeast, together with β-amyrin synthase and a CYP reductase, revealed that two CYP716A enzymes from TBGC-2 catalyze distinct oxidative reactions of oleanane-type triterpenoids. AwCYP716A1278 converts β-amyrin to 21β-hydroxyl-β-amyrin, whereas AwCYP716A277 produced 28-hydroxyl-β-amyrin and oleanolic acid. Molecular docking and mutational analyses identified key amino acid residues that determine product specificity. In addition, functional characterization of a neofunctionalized oxidosqualene cyclase, AwOSC13 from TBGC-4, revealed a previously unknown biosynthetic pathway leading to hop-17(21)-en-3β-ol and an uncharacterized triterpenoid. Structural elucidation using NMR and mass spectrometry identified this compound as moretenol. Heterologous expression of AwOSC13 in tobacco successfully reconstituted this pathway in planta. Together, these findings demonstrate how biosynthetic gene clusters and enzyme diversification shape triterpenoid metabolism in A. wilsonii and provide valuable genomic and biochemical resources for the discovery and engineering of bioactive plant natural products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.